Annovis Bio Inc.

86.30-2.55-2.87%Vol 468.99K1Y Perf 1 807.05%
Jun 15th, 2021 16:00 DELAYED
BID86.00 ASK86.27
Open85.54 Previous Close88.85
Pre-Market- After-Market-
 - -  - -%
Target Price
45.00 
Analyst Rating
— — 0.00
Potential %
-47.86 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap599.53M 
Earnings Rating
Price Range Ratio 52W %
87.60 
Earnings Date
15th Jun 2021

Today's Price Range

83.3987.87

52W Range

3.8497.97

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
24.17%
1 Month
256.32%
3 Months
159.16%
6 Months
1 350.42%
1 Year
1 807.05%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ANVS86.30-2.5500-2.87
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Earnings HistoryEstimateReportedSurprise %
Q02 2020--0.34-
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume468.99K
Shares Outstanding6.95M
Trades Count5.39K
Dollar Volume5.97M
Avg. Volume827.25K
Avg. Weekly Volume853.53K
Avg. Monthly Volume3.51M
Avg. Quarterly Volume1.23M

Annovis Bio Inc. (AMEX: ANVS) stock closed at 86.3 per share at the end of the most recent trading day (a -2.87% change compared to the prior day closing price) with a volume of 474.28K shares and market capitalization of 599.53M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 2 people. Annovis Bio Inc. CEO is Maria Maccecchini.

The one-year performance of Annovis Bio Inc. stock is 1807.05%, while year-to-date (YTD) performance is 1044.56%. ANVS stock has a five-year performance of %. Its 52-week range is between 3.84 and 97.97, which gives ANVS stock a 52-week price range ratio of 87.60%

Annovis Bio Inc. currently has a PE ratio of -75.20, a price-to-book (PB) ratio of 144.73, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -90.65%, a ROC of -109.16% and a ROE of -104.44%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Annovis Bio Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Annovis Bio Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Annovis Bio Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Annovis Bio Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Annovis Bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Annovis Bio Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 36.11, ATR14 : 9.78, CCI20 : 118.36, Chaikin Money Flow : -0.24, MACD : 14.61, Money Flow Index : 76.60, ROC : 93.50, RSI : 74.04, STOCH (14,3) : 81.46, STOCH RSI : 0.35, UO : 54.93, Williams %R : -18.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Annovis Bio Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Annovis Bio Inc.

Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

CEO: Maria Maccecchini

Telephone: +1 610 727-3913

Address: 1055 Westlakes Drive, Berwyn 19312, PA, US

Number of employees: 2

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

88%13%

Bearish Bullish

62%38%

Bearish Bullish

63%38%

News

Stocktwits